TUMOR NECROSIS FACTOR INHIBITORS

You have access
High-density Lipoprotein Profiling Changes in Patients with Rheumatoid Arthritis Treated with Tumor Necrosis Factor Inhibitors: A Cohort Study
Anna Jamnitski, Johannes H. Levels, Inge A. van den Oever and Michael T. Nurmohamed

The Journal of Rheumatology June 1 2013, 40 (6) 825-830; DOI: https://doi.org/10.3899/jrheum.121358
You have access
Soluble Biomarkers Associated with Response to Treatment with Tumor Necrosis Factor Inhibitors in Psoriatic Arthritis
Vinod Chandran, Hua Shen, Remy A. Pollock, Fawnda J. Pellett, Adele Carty, Richard J. Cook and Dafna D. Gladman

The Journal of Rheumatology June 1 2013, 40 (6) 866-871; DOI: https://doi.org/10.3899/jrheum.121162
You have access
Patterns and Associated Risk of Perioperative Use of Anti-Tumor Necrosis Factor in Patients with Rheumatoid Arthritis Undergoing Total Knee Replacement
Beverly K. Johnson, Susan M. Goodman, Michael M. Alexiades, Mark P. Figgie, Ryan T. Demmer and Lisa A. Mandl

The Journal of Rheumatology May 1 2013, 40 (5) 617-623; DOI: https://doi.org/10.3899/jrheum.121171

Main menu